Sex: U
Vaccine: COVID19-2
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: No adverse event; 1 Patient received a dose of Moderna COVID19 vaccine with lot #019D22A as an additional booster/HCP would like to know if the following vaccine lot #019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (1 Patient received a dose of Moderna COVID19 vaccine with lot #019D22A as an additional booster/HCP would like to know if the following vaccine lot #019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (1 Patient received a dose of Moderna COVID19 vaccine with lot #019D22A as an additional booster/HCP would like to know if the following vaccine lot #019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (1 Patient received a dose of Moderna COVID19 vaccine with lot #019D22A as an additional booster/HCP would like to know if the following vaccine lot #019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (1 Patient received a dose of Moderna COVID19 vaccine with lot #019D22A as an additional booster/HCP would like to know if the following vaccine lot #019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine).    No concomitant medications were reported. Caller stated she did not have further information to disclose at the moment of the call Commercial agent stated that the HCP mentioned that the patient received in the past different brands of COVID19 vaccines, The vaccine lot 019D22A corresponds to a monovalent Moderna COVID19 vaccine or a bivalent Moderna COVID19 vaccine. No treatment medications were reported.